It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...
Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...
One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...
Well, a global provider of genomic library and multiplexing workflow solutions, today announced the launch of AgriPreptm Library Prep Kit, the newest addition to its next-generation TnXtm transposase ...
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Next-Generation ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Biotechnology instruments market size was valued at USD 92.12 billion in 2025 and is projected to hit the market valuation of USD 141.70 billion by 2035 at a CAGR of 4.4% during the forecast period ...
Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Amanda Jackson has expertise in personal finance, investing, and social services. She is a ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Plus, hospitals embrace AI—for better and worse—and scientists create a robot smaller than a grain of sand. The opportunity for everyday folks to enhance their lives and work with AI has never been ...
For 33 years, we've provided live analysis and coverage of stocks in play, market-moving events, news headlines, corporate earnings, broker rating changes, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results